Understand the importance of targeted assays in personalised medicine and how early decisions shape clinical outcomes.

One recent obstacle to drug delivery research is an observed weak correlation between in vitro and in vivo performance. When nanoparticles are applied intravenously, they face several obstacles that ...

insights from industryNatalie Strickland Global Head of Translational ScienceSynexa Life Sciences In this interview, News Medical speaks with Natalie Strickland, Global Head of Translational Science ...

Scientists and public health experts built the COVID-19 pandemic response on years of experience navigating infectious disease outbreaks. Although lateral flow immunoassays have been central to ...

In today’s evolving diagnostic landscape, limitations in assay sensitivity and stability can quickly become barriers to reliable at-home testing. Developers and manufacturers must balance performance, ...

Targeted Protein Degradation (TPD) is an emerging drug modality that enables specific degradation of protein targets, offering a powerful approach to tackle previously undruggable targets including ...

The Total Oxidizable Precursor assay has identified higher levels of PFAS in birds than previously recorded. A research team from the Norwegian University of Science and Technology (Trondheim, Norway) ...